Dual emission laser treatment and argon plasma coagulation in small bowel vascular lesion ablation: a pilot study
- 13-07-2022
- Acetylsalicylic Acid
- Brief Report
- Authors
- Gian Eugenio Tontini
- Alessandro Rimondi
- Lucia Scaramella
- Matilde Topa
- Roberto Penagini
- Maurizio Vecchi
- Luca Elli
- Published in
- Lasers in Medical Science | Issue 9/2022
Excerpt
The 1.9/1.5 μm dual emission endoscopic laser treatment (1.9/1.5 μm DEELT) is a recent endoscopic tool that has been demonstrated as safe and effective in the treatment of vascular gastrointestinal lesions [1‐4]. The intrinsic flexibility and manoeuvrability of the laser fibre, together with a precise photo-coagulative effect, are theoretically ideal characteristics for enteroscopic procedures. To date, there are no studies assessing the safety and efficacy of the 1.9/1.5 μm DEELT in the treatment of small bowel vascular lesions [5]. We attempted to provide answers to these open questions in a retrospective study comparing the 1.9/1.5 μm DEELT with a historical, random forest–matched cohort of argon plasma coagulation (APC)–treated small bowel enteroscopic procedures. …
Advertisement
- Title
- Dual emission laser treatment and argon plasma coagulation in small bowel vascular lesion ablation: a pilot study
- Authors
-
Gian Eugenio Tontini
Alessandro Rimondi
Lucia Scaramella
Matilde Topa
Roberto Penagini
Maurizio Vecchi
Luca Elli
- Publication date
- 13-07-2022
- Publisher
- Springer London
- Keywords
-
Acetylsalicylic Acid
Acetylsalicylic Acid
Laser
Packed Red Blood Cell
Low Molecular Weight Heparin - Published in
-
Lasers in Medical Science / Issue 9/2022
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X - DOI
- https://doi.org/10.1007/s10103-022-03608-x
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.